Member Info for Blessed22

We should hopefully get more interest in the media besides vaccines when P3 start.
Once treatments will be regarded as important as vaccines we ll bounce back and leave all this behind.
Patience once again.

@jollyspeculator

Well said. Couldn't explain it in a better way.

ATB

@joey

The company must be well aware of these dates and the effect that news of a vaccine approval could have in terms of sentiment towards the company if nothing is announced soon.
They must come out with something positive before December 2nd, better this week, to avoid another sell off as two weeks ago.
I have my trust in RM and the company but NOW is time to ACT and release something.
P3 to be started in Q4. I think is about time???

@eva

I can see sub 80 on vaccines roll out news.
There should be some buying pressure below 90 correct.

One sure thing we won't see 100+ until some company announcement.

Regulatory pathway

"Following a positive pre-Investigational New Drug (IND) Application meeting with the U.S. Food and
Drug Administration (FDA) regarding the design of a Phase III randomised placebo-controlled trial of
SNG001 in hospitalised COVID-19 patients, and with manufacturing scale-up activity underway, the
Company is pleased to announce the proposed Fundraising of up to £87.0 million to support the Phase
III clinical development and supply chain scale-up of SNG001 for COVID-19 patients.

The FDA has reviewed the SNG001 pre-IND materials including preclinical and Chemistry and
Manufacturing Control (CMC) data, the results of the Phase II study in COVID-19 patients and the
proposed Phase III protocol. The FDA has provided Synairgen with guidance on the Phase III clinical
study to support the potential registration of SNG001 for the treatment of COVID-19.
The Company plans to file an IND application as soon as possible to allow the Phase III study to be initiated. Synairgen will continue to work closely with the FDA as development continues."

Atb

The price for treatment was given during the webinar.

Have a good Sunday everyone

@alinz

SNG 3k per treatment.
A 14 day treatment ( 14 doses)

Next week we should hear about FDA Ind application and P3 start.
If anyone wanted to load up cheaply this is the time.

Remember the placing price was 175p, trial registered in the NIHR website, IND done, other countries' approval coming and home trial soon completed.
Quite an amount of fresh news to be released.
Draw your conclusions.

GLA

It will be the year when Synairgen and its drug SNG001 will be recognised globally as they deserve.

Currently it's only speculation.
The Ones who have a good insight of the company know where we stand.
Medical political agendas, suppression of science and CEO trying to pump their companies to fill their pockets is what we have been seeing since the beginning.

RM knows which path to follow regardless.

One/two months will be in a better position than now, once vaccines will be "rolled out" the market will react knowing that vaccines are not the silver bullet.

Treatments wil be always needed in the near and long term, not only for covid ( 3.6 billions 2021 estimate).
If you are here to make some quick money this is not your place, study the company and then talk).

Nevertheless, not long to wait now, P3 is around the corner and as other trials which have been stopped before completion after having shown efficacy, ours will get the approval before having recruited all the patients, beginning of the new year. And then deals with big pharmas ( RM said about 15 potential pharmas among the 30 world largest) can take place.

My target is still 7/8 Billions buy out in early spring.

"As Blessed said on November 20th..."
We shall see.

GLA

@Elsol
What a crock of sh*t your post!

Recycled

Almost whole Europe
Plus Brazil Argentina Colombia Chile Mexico Peru Canada USA Russia Israel India Ukraine and South Africa.

Quite an undertaking!
Marvellous!

10yen

My message was not pointed at you but at another poster who said that we missed the boat with covid. Clearly he/she is not very informed about the facts and haven't done enough research into the company.
My first message was a reply to you saying that we could see the placing price again soon once p3 is officially underway.
As you I am eager to see this being rolled out soon!
Best of luck for your investment.

They have missed nothing.
RM said that until winter 2021/2022 there will be high demand.

And we due respect I think he knows more than you.

GLA

With P3 underway we will be back within that price range.
Anytime soon.

Initial broker target of 7£
Without considering 100k doses per months for governments' stockpiling the drug ( 3k per treatment)
And future Pharmas' deals.

Without a deal with a major pharma company a 3.6 Billions forecast for the year 2021 is alone something to look forward to. Very exciting.

As RM said the drug could be used in future in both hospital or home settings for any viral pulmonary related infection as the first choice of broad spectrum antivral.

Great presentation, very positive.

GLA

Eva you are not working today?
I know..every industry has been hit by the pandemic.
Green bin

The IND application should come into effect this week.
And we need updates regarding how phase III is progressing.
In the light of an upcoming webinar set up with the intention to discuss the current scenario and the future steps to be undertaken, the company should release an update before the webinar starts. Intraday would be better.
Or all the expectations about this "great" webinar will not be met. They will further discuss the points already made precedently with no impact whatsoever.

We shall see
GLA

That article summarise eveything.
Science is being suppressed for political and financial gain. Covid-19 has unleashed state corruption on a grand scale, and it is harmful to public health.
When science is suppressed from the medical political agenda people die.
UK government the only one to blame.

Everyone seems very optimistic this morning but I can't see any of these reflections in the SP.
New inflation rates published this morning had also an effect on the SP I would think.

An intraday RNS about IND application or phase III update would be useful, otherwise, if you ever happen to look at the chart, closing below the 200MA at 103 could bring us down to 80p.

Conclusion is that if no news are released the illusions for a quick recover in the SP will soon fade.

Let's see what the afternoon will bring.
I have been here till March, I appreciate everyone optimism but being realistic is another matter.

GLA

Some conclusions from AZ video (Italian is my first language).
AZ during his presentation clearly said that shortly
He will announce a new UK partner worth 500m £ and give us confirnation of the first securitazion.

"Shortly" to me could well mean before the end of the month.
In the meantime breaking the resistance level at 0.38 would be already an achievement for a prospective uptrend to 0.60.

GLA